MaxLinear director sells shares after RSU vesting
MaxLinear, Inc. director Albert J. Moyer reported a routine compensation-related share exercise followed by a sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MaxLinear, Inc. director Albert J. Moyer reported a routine compensation-related share exercise followed by a sale. On May 1, 2026, 15,741 restricted stock units vested, and he acquired the same number of common shares through a derivative exercise.
On May 4, 2026, he conducted an open-market sale of 15,741 common shares at $78.00 per share. After these transactions, Moyer directly held 72,793 shares of MaxLinear common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 15,741 | $78.00 | $1.23M |
| Exercise | Restricted Stock Units | 15,741 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,741 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
- F2. One hundred percent (100%) of the RSUs subject to the award vested on May 1, 2026.
Key Figures
Key Terms
Restricted Stock Units financial
RSU financial
derivative exercise/conversion financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MaxLinear (MXL) director Albert J. Moyer report in this Form 4?
What happened to Albert J. Moyer’s restricted stock units in MaxLinear (MXL)?
Was this MaxLinear (MXL) Form 4 mainly a sale or an option/RSU exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.